STRUCTURE–ACTIVITY RELATIONSHIP AND MOLECULAR DOCKING STUDIES OF NEW BIOACTIVE HETEROCYCLIC DERIVATIVES

Authors

  • Daniel R. Whitmore Department of Pharmaceutical Sciences, Center for Molecular Research, Chicago, Illinois, USA

Keywords:

benzimidazole; 1,2,3-triazole; heterocyclic derivatives; structure–activity relationship; molecular docking; DNA gyrase B; drug design.

Abstract

Heterocyclic scaffolds remain a major source of lead structures in medicinal chemistry because they enable controlled variation of hydrogen-bonding capacity, aromaticity, polarity, lipophilicity and three-dimensional recognition features. This study develops a structure–activity relationship (SAR) and molecular-docking framework for a focused series of eight benzimidazole–1,2,3-triazole hybrids (B1–B8) proposed as bioactive heterocyclic derivatives. The series contains para-substituted phenyl analogues (H, F, Cl, Br, CH3, OCH3, CF3 and CN) selected to probe electronic, steric and lipophilic effects while preserving a common heteroaromatic core. Molecular descriptors were calculated from canonical structures, including molecular weight, cLogP, topological polar surface area (TPSA), hydrogen-bond acceptors/donors, rotatable bonds and quantitative estimate of drug-likeness (QED). A transparent ligand-prioritization score was additionally used to compare balanced physicochemical profiles; this score is explicitly distinct from a docking affinity. For the structure-based component, the ATP-binding domain of Staphylococcus aureus DNA gyrase B (GyrB; PDB 3TTZ) was selected as a validated antibacterial target. A reproducible AutoDock Vina protocol is specified, including native-ligand redocking, active-site definition and post-docking interaction analysis. Descriptor analysis showed that all B1–B8 analogues remained within conventional drug-like physicochemical space, with cLogP values of 2.14–3.28 and TPSA values of 72.28–96.07 Ų. B2, B3 and B5 achieved the highest multi-parameter prioritization scores, whereas B6 offered the greatest polarity without excessive loss of lipophilicity. SAR interpretation suggests that halogenation can strengthen hydrophobic and polarizable contacts, methoxy substitution may improve directional polar recognition, and cyano substitution increases acceptor capacity but may reduce permeability if polarity is pushed too far. The study provides an OAK-compatible, reproducible computational framework for selecting heterocyclic candidates for subsequent docking execution, synthesis and biological testing while avoiding unsupported numerical docking claims.

 

References

Silver, L. L. (2011). Challenges of antibacterial discovery. Clinical Microbiology Reviews, 24(1), 71–109. https://doi.org/10.1128/CMR.00030-10

2. Omar, M. A., Temirak, A., Abdelraof, M., El-Bayaa, M. N., Alanzy, A. L., Saleh, A., & Srour, A. M. (2026). Design and synthesis of benzimidazole-based derivatives with antimicrobial activity: Mechanistic insights into ROS-mediated oxidative damage, hemolytic assessment, and molecular docking studies. Bioorganic Chemistry, 174, 109736. https://doi.org/10.1016/j.bioorg.2026.109736

3. Dighe, S. N., & Collet, T. A. (2020). Recent advances in DNA gyrase-targeted antimicrobial agents. European Journal of Medicinal Chemistry, 199, 112326. https://doi.org/10.1016/j.ejmech.2020.112326

4. Janupally, R., Jeankumar, V. U., Bobesh, K. A., Soni, V., Devi, P. B., Pulla, V. K., Suryadevara, P., Chennubhotla, K. S., Kulkarni, P., Yogeeswari, P., & Sriram, D. (2014). Structure-guided design and development of novel benzimidazole class of compounds targeting DNA gyraseB enzyme of Staphylococcus aureus. Bioorganic & Medicinal Chemistry, 22(21), 5970–5987. https://doi.org/10.1016/j.bmc.2014.09.008

5. Abdel-Motaal, M., Almohawes, K., & Tantawy, M. A. (2020). Antimicrobial evaluation and docking study of some new substituted benzimidazole-2yl derivatives. Bioorganic Chemistry, 101, 103972. https://doi.org/10.1016/j.bioorg.2020.103972

6. Aroso, R. T., Guedes, R. C., & Pereira, M. M. (2021). Synthesis of computationally designed 2,5(6)-benzimidazole derivatives via Pd-catalyzed reactions for potential E. coli DNA gyrase B inhibition. Molecules, 26(5), 1326. https://doi.org/10.3390/molecules26051326

7. Çevik, U. A., Işık, A., Evren, A. E., Kapusız, Ö., Gül, Ü. D., Özkay, Y., & Kaplancıklı, Z. A. (2022). Synthesis of new benzimidazole derivatives containing 1,3,4-thiadiazole: Their in vitro antimicrobial, in silico molecular docking and molecular dynamic simulations studies. SAR and QSAR in Environmental Research, 33(11), 899–914. https://doi.org/10.1080/1062936X.2022.2149620

8. Mendapara, J. V., Vaghasiya, M. D., Rajani, D. P., Ahmad, I., Patel, H., & Kumari, P. (2024). Benzimidazole and piperidine containing novel 1,2,3-triazole hybrids as anti-infective agents: Design, synthesis, in silico and in vitro antimicrobial efficacy. Journal of Biochemical and Molecular Toxicology, 38(1), e23526. https://doi.org/10.1002/jbt.23526

9. Trott, O., & Olson, A. J. (2010). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2), 455–461. https://doi.org/10.1002/jcc.21334

10. Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785–2791. https://doi.org/10.1002/jcc.21256

11. Eberhardt, J., Santos-Martins, D., Tillack, A. F., & Forli, S. (2021). AutoDock Vina 1.2.0: New docking methods, expanded force field, and Python bindings. Journal of Chemical Information and Modeling, 61(8), 3891–3898. https://doi.org/10.1021/acs.jcim.1c00203

12. Burley, S. K., Berman, H. M., Bhikadiya, C., et al. (2019). RCSB Protein Data Bank: Biological macromolecular structures enabling research and education in fundamental biology, biomedicine, biotechnology and energy. Nucleic Acids Research, 47(D1), D464–D474. https://doi.org/10.1093/nar/gky1004

13. Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 46(1–3), 3–26. https://doi.org/10.1016/S0169-409X(00)00129-0

14. Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002). Molecular properties that influence the oral bioavailability of drug candidates. Journal of Medicinal Chemistry, 45(12), 2615–2623. https://doi.org/10.1021/jm020017n

15. Laskowski, R. A., & Swindells, M. B. (2011). LigPlot+: Multiple ligand–protein interaction diagrams for drug discovery. Journal of Chemical Information and Modeling, 51(10), 2778–2786. https://doi.org/10.1021/ci200227u

Published

2026-09-18